Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

CARM 11.27.2024

Full Press ReleaseSEC FilingsOur CARM Tweets

About Gravity Analytica

Recent News

  • 12.09.2024 - Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
  • 12.05.2024 - 7th Annual Evercore ISI HealthCONx Conference
  • 11.27.2024 - Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Recent Filings

  • 01.13.2025 - 8-K Current report
  • 01.02.2025 - 3 Initial statement of beneficial ownership of securities
  • 11.07.2024 - EX-99.1 EX-99.1

PHILADELPHIA,Nov. 27, 2024/PRNewswire/ --Carisma Therapeutics Inc.(Nasdaq:CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced thatSteven Kelly, President and Chief Executive Officer, will participate in a fireside chat at the 7thAnnualEvercore ISI HealthCONx ConferenceonThursday, December 5that9:35 am ET.

(PRNewsfoto/CARISMA Therapeutics Inc.)

An audio webcast of the event will be available on the Company'sInvestor Eventssection of the Investor Relations webpage and will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics Inc.is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered inPhiladelphia, PA.For more information, please visitwww.carismatx.com.

Investors:Shveta DigheHead of Investor Relationsinvestors@carismatx.com

Media Contact:Julia Stern(763) 350-5223jstern@realchemistry.com

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-the-7th-annual-evercore-isi-healthconx-conference-302316979.html

SOURCECarisma Therapeutics Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com